OBJECTIVE To evaluate the impact of maternal hypothyroxinaemia during early gestation (fT4 below the lowest tenth percentile and TSH within the reference range: 0·15-2·0 mIU/ l) on infant development, together with any subsequent changes in fT4 during gestation. DESIGN A prospective 3-year follow-up study of pregnant women and their children up to the age of 2 years. MEASUREMENTS Child development was assessed by means of the Bayley Scales of Infant Development in children of women with hypothyroxinaemia (fT4 below the tenth percentile at 12 weeks' gestation) at 12 weeks' gestation (cases), and in children of women with fT4 between the 50th and 90th percentiles at 12 weeks' gestation, matched for parity and gravidity (controls). Maternal thyroid function (fT4 and TSH) was assessed at 12, 24 and 32 weeks' gestation. The mental and motor function of 63 cases and 62 controls was compared at the age of 1 year, and of 57 cases and 58 controls at the age of 2 years. RESULTS Children of women with hypothyroxinaemia at 12 weeks' gestation had delayed mental and motor function compared to controls: 10 index points on the mental scale (95% CI: 4·5-15 points, P = 0·003) and eight on the motor scale at the age of 1 year (95% CI: 2·3-12·8 points, P = 0·02), as well as eight index points on the mental (95% CI: 4-12 points, P = 0·02), and 10 on the motor scale (95%CI: 6-16 points, P = 0·005) at the age of 2 years. Children of hypothyroxinaemic women in whom the fT4 concentration was increased at 24 and 32 weeks' gestation had similar scores to controls, while in the controls, the developmental scores were not influenced by further declines in maternal fT4 at 24 and 32 weeks' gestation.
on the motor scale (95%CI: 6-16 points, P = 0·005) at the age of 2 years. Children of hypothyroxinaemic women in whom the fT4 concentration was increased at 24 and 32 weeks' gestation had similar scores to controls, while in the controls, the developmental scores were not influenced by further declines in maternal fT4 at 24 and 32 weeks' gestation.
CONCLUSIONS Maternal hypothyroxinaemia during early gestation is an independent determinant of a delay in infant neurodevelopment. However, when fT4 concentrations increase during pregnancy in women who are hypothyroxinaemic during early gestation, infant development appears not to be adversely affected.
In the past decade, interest has been rekindled in the relationship between maternal plasma thyroid hormone concentration during pregnancy and subsequent infant neurodevelopment (Pop et al ., 1995 (Pop et al ., , 1999a Haddow et al ., 1999; Lazarus, 1999; Smit et al ., 2000) . It is well known that both maternal thyroid dysfunction during pregnancy (especially hypothyroidism) and severe iodine deficiency adversely affect the outcome of neurodevelopment in children (Delange, 1994; Glinoer, 1997; Mestman, 1999) . Even in areas in which there is sufficient iodine intake in the general population, pregnant women often have fT4 plasma levels in the lower ranges, without elevated TSH. This is defined as hypothyroxinaemia, and is generally regarded as a normal condition. However, there is growing concern that hypothyroxinaemia during early gestation could be harmful to the offspring (Pop et al ., 1999b; Utiger, 1999; Morreale de Escobar et al ., 2000) . In fact, little is known about maternal fT4 levels during normal pregnancy, or their relationship to the development of the child. This paper describes the results of a longitudinal prospective study that investigates whether maternal thyroid hormone levels, assessed in women without (sub)clinical thyroid function at three different trimesters during pregnancy, are adversely related to child development at 1 and 2 years of age.
Design

Patients
Between January 1997 and April 1998, thyroid parameters [TSH, fT4 and thyroid peroxidase antibodies (TPO-Ab)] were assessed at 12 weeks' gestation in a randomly newly selected cohort of 1361 Dutch Caucasian women at their first antenatal visit in and around the city of Eindhoven, the Netherlands (Fig. 1) . After exclusion of women with overt thyroid dysfunction ( n = 8) in the first 220 of the remaining 1353 women, the lowest 10th, and the 50th − 90th, fT4 percentiles were calculated within the first 10 weeks' of inclusion: 12·1 and 15·4 -19·0 pmol/ l, respectively. Thereafter, a further calculation was performed after every consecutive 150 women, which, after minor changes, resulted in the final cut-off scores for the total sample for the 10th (12·4 pmol / l) and 50th-90th (15·6-19·1 pmol/l) percentiles. The 135 women in the lowest fT4 percentile (cases) were matched for parity and gravidity with an equal number of women whose fT4 values were between the 50th and 90th fT4 percentiles (controls). All these women ( n = 270) were invited to participate in a followup study. Women were excluded on previously set exclusion criteria (fertility problems; presence of autoimmune diseases such as rheumatoid arthritis, or insulin-dependent diabetes mellitus). The remaining 238 women were visited at home at 24 and 32 weeks' gestation for repeated assessments of thyroid function and gestational complications. Subsequently, a careful obstetrical history was obtained at 3 weeks' postpartum. At 1 and 2 years after delivery, the women's general medical history (period of breastfeeding, serious diseases, chronic drug intake, lifestyle habits) was assessed during a home interview, during which any episodes of major depression were also assessed. One woman and two children died during the study period (not related to thyroid function).
In the remaining 235 women and their children, no thyroid parameters were obtained in 21 women at 24 and /or 32 weeks' gestation. Forty-four women with subclinical thyroid dysfunction (TSH outside the reference range with normal fT4) were excluded. There were no women who developed clinical hyperor hypothyroidism (TSH and fT4 outside reference range) during gestation. Furthermore, data of mothers and infants suffering from potentially confounding circumstances were also excluded: 18 women with obstetrical complications such as abortion, gestational diabetes, gemelli pregnancy and pre/post-term delivery (< 37 or > 42 weeks' gestation); 19 women who reported at least one episode of major depression during pregnancy or in the first postpartum year. Three children were excluded because of low birth weight (< 2500 g) and five because of their longterm hospitalization. Consequently, at the age of 1 year, the data of 125 children and their mothers were eligible for analysis, as follows: 63 cases (hypothyroxinaemia at 12 weeks' gestation: fT4 below the 10th percentile and TSH within the reference range), and 62 controls (fT4 at 12 weeks' gestation between the 50th and 90th percentiles, and TSH within the reference range; Fig. 1 ). All these 125 children had normal Apgar scores at birth and normal screening results for congenital hypothyroidism on the seventh postpartum day. None of these children was taking any chronic medication known to interfere with neurodevelopment. The characteristics of these two groups are presented in Table 1 .
With regard to the analysis at 2 years' postpartum, a further nine women who had undergone a major episode of depression were also excluded. One child was excluded because of repeated long-term hospitalization. There was no change in the marital status of any of the parents between these two assessment dates. Therefore, data analysis of infant development at 2 years includes 115 children: 57 cases and 58 controls (Fig. 1) .
This study was approved by the Medical Ethical Committee of St Joseph Hospital, Veldhoven, the Netherlands.
Measurements
Thyroid parameters. TSH (reference range for women aged between 20 and 40 years: 0·15-2·0 mIU/ l) was measured using a solid-phase, two-site chemiluminescent enzyme immunometric assay (IMMULITE third generation TSH, Diagnostic Corporation, Los Angeles, CA, USA). The interassay coefficients of variation were 9·8, 6·9 and 4·6%, at concentrations of 0·02, 0·15 and 11mIU/ l, respectively. The fT4 concentration (reference range for women aged between 20 and 40 years: 8·7-19·6 pmol/ l) was also measured by means of a solid-phase immunometric assay (IMMULITE Free T4). The interassay coefficients of variation for this technique were 20, 5·3 and 5·2% at concentrations of 3·1, 19·8 and 55 pmol/ l, respectively. The IMMULITE Anti-TPO-Ab kit was used to determine antibodies against TPO. The interassay coefficients of variation for this analysis were 19·9, 13·0 and 13·4% for concentrations of 36, 69 and 114 IU/ml, respectively. The anti-TPO assay was standardized according to the International Reference Preparation for anti-TPO MRC 66/387. A concentration of between 35 and 100 IU/ml was regarded as moderately elevated, while one of > 100 IU/ml was regarded as clearly elevated.
Infant development
Infant development was assessed at 1 and 2 years of age using the Dutch version of Bayley Scales of Infant Development (Van der Meulen & Smrkovsky, 1983) . The Mental Scale of the Bayley test evaluates aspects of functioning, such as eye-hand coordination, manipulation, understanding the relationship of objects, imitation and early language development. The Psychomotor Scale assesses gross motor development. The Dutch Bayley Scales result in a Mental Developmental Index (MDI) and a Psychomotor Developmental Index (PDI) with a mean of 100 and a standard deviation of 16. A group difference between 0·5 and 1SD (8-16 index points) is regarded as clinically relevant, a score between 1 and 2SD under the norm (84-68) as delayed (reflecting a developmental delay of 2-4 months and of 3-5 months at 1 and 2 years, respectively), and a difference of > 2SD as deviantly delayed development. The investigators, who were blinded regarding maternal thyroid function during pregnancy, visited all the children at home. Table 1 Characteristics of the cases children (of women with hypothyroxinaemia at 12 weeks' gestation: n = 63, fT4 < 10th percentile and TSH within reference range: 0·15-2mIU/ l) and the control children (n = 62, fT4 between the 50th and 90th percentiles and TSH within reference range) 
Statistical analysis
Statistical analysis was performed using the Statistical Package of Social Science and Problems Solutions (SPSS). Differences in characteristics between the cases and controls were analysed by means of the χ 2 test. The differences in scores between the children of cases and controls were compared using the t -test (two-tailed). Within the cases group ( n = 57) correlations between maternal fT4 levels at 12 weeks' gestation and neurodevelopment scores at 2 years of age were analysed using linear regression. Odds ratios (OR) were calculated using logistic regression analysis.
Results
The mean Bayley mental and motor scores (SD) of the cases and controls at 1 and 2 years of age are shown in Table 2 . At 1 year of age, the group differences were statistically significant, with a mean difference of 10 index points for the mental scale and eight for the motor scale. Nineteen children who showed a delay in mental function (scores < 84) were examined, 15 of whom (79%) had hypothyroxinaemic mothers. Similarly, 21 children showed a delay in motor function, 16 of whom (76%) had hypothyroxinaemic mothers. At the age of 2 years, 57 children of the cases had a statistically significant lower mean score: eight index points on the mental scale and 10 on the motor scale; compared to 58 children of the controls. Eleven children showed a delay on the mental scale, eight of whom (73%) had hypothyroxinaemic mothers. Similarly, 22 children had delayed motor function, 17 of whom (77%) were from the hypothyroxinaemic group. Of the 29 children who showed a delay in mental or motor function at 2 years, 14 (48%) had already been assessed as delayed at the age of 1 year. Similarly, with regard to those children with assessments at 1 and 2 years of age, of the 27 children who had been assessed as delayed in mental or motor function at 1 year of age, 14 (52%) were also delayed at 2 years of age. Figure 2 shows the distribution of Bayley scores in cases and controls at 2 years of age, by means of the pattern of maternal fT4 concentrations at three assessments during gestation. In the children of hypothyroxinaemic women, an increase of mean maternal fT4 at between 12 and 24 weeks' gestation, followed by a further increase at between 24 and 32 weeks ( n = 15), resulted in similar mental and motor scores compared to the 50-90th percentile group (cases). Lower mental and motor scores were found in cases in which the maternal fT4 levels decreased at between 12 and 24 weeks' or 24 and 32 weeks' gestation. The greatest differences were observed in cases ( n = 8) in which maternal fT4 decreased at between 12 and 24 weeks' gestation, and subsequently at between 24 and 32 weeks'. In the children of 56 of the 59 women with fT4 between the 50th and 90th percentiles, the mean decrease of fT4 at between 12 and 24 weeks' gestation, followed by a further decrease in 20 women at between 24 and 32 weeks' gestation, was not associated with lower Bayley scores (Fig. 2) . A linear regression correlating maternal fT4 levels at 12 weeks' gestation of the cases ( n = 57) with mental and psychomotor scores on the Bayley scale at 2 years of age showed highly significant (but moderate) correlations: R = 0·48 ( P = 0·001) and R = 0·38 ( P = 0·006), respectively, as shown in a scatter diagram in Fig. 3 .
Discussion
This is the first study to be published that investigates the relationship between repeatedly assessed fT4 concentrations in Table 2 Differences on the Bayley mental (MDI) and motor (PDI) subscales -assessed both at 1 and 2 years -of 57 children of mothers with hypothyroxinaemia (an fT4 ≤ 10th percentile, cases) during early gestation and 58 children of mothers with an fT4 between the 50th and 90th percentiles controls (t-test, two tailed) hypothyroxinaemic women during the gestation and neurodevelopment of their offspring. The findings show that children of women with hypothyroxinaemia (fT4 levels below the 10th percentile with TSH levels within the reference range) during the first trimester of pregnancy are at risk of having a delay in both mental and motor development at the age of 1 year, as well as at 2 years. In addition, this study also shows that the actual course of maternal fT4 concentrations during pregnancy is important for the development of the offspring. This was observed in the children of women who had hypothyroxinaemia during early gestation and who exhibited a further decrease of fT4 during gestation: these children had the lowest scores. In contrast, children whose mothers showed early hypothyroxinaemia, but whose fT4 levels increased during later gestation, did not show any delay in development. Children of women who had higher levels of fT4 (50th − 90th percentile) during early pregnancy showed normal neurodevelopment, which was not affected by a further decrease of maternal fT4 levels during pregnancy. By definition, hypothyroxinaemia refers to a condition with an fT4 in the lower range, and TSH values within the reference range. In this study, the reference range for TSH is rather restricted, but is similar to that suggested in the longitudinal Whickham Survey data (Vanderpump et al ., 1995) .
The association between maternal fT4 during pregnancy and infant development could be mediated by other independent factors. Therefore, several steps were taken to prevent known confounding variables from affecting the results. Maternal depression -during both pregnancy and the first years postpartum -is associated with poor infant outcome (Murray et al ., 1996; Weinberg & Tronick, 1998) . Therefore, the data of women who suffered from at least one episode of major depression during the follow-up period were excluded. Several pregnancy-and infant-related factors, which could interfere with child outcome, were also reasons for exclusion, as described in the design section. Other factors (Lucas et al ., 1992; Olds et al ., 1994; Frydman, 1996; Seagull et al ., 1996) , such as the demographic details of the parents (educational level, marital status) and the lifestyle habits of the mother (alcohol intake and smoking during pregnancy), were equally distributed between cases and controls.
This study had several limitations, which should be mentioned. The subgroups defined according to maternal fT4 patterns during pregnancy became rather small after cases with potentially confounding data had been excluded. Therefore, although timeconsuming and expensive, even larger epidemiological studies are needed for accurate investigation of the relationship between the course of maternal fT4 levels during pregnancy and the neurodevelopment of the offspring. It should be remembered that different skills may be affected by different (critical) periods of gestation, during which the maternal fT4 is low, and as a consequence, these may be differentially sensitive to low maternal thyroid levels at various times during gestation (Mirabella et al ., 2000) .
Investigation of the relation between one biological maternal determinant during gestation (in this case thyroid function) and subsequent infant development is a difficult matter. At one hand -because during early childhood many (psychosocial) factors interfere with infant development -one should investigate the impact of maternal thyroid function during gestation on subsequent neurodevelopment of the offspring preferentially during gestation (which is technically and ethically almost impossible) or immediately after birth. On the other hand, assessment of infant development at an early age still has only a limited value regarding the prediction of a child's abilities once it has reached school age. This is especially true of Bayley scores at 1 year of age, while at 2 years of age, these scores are related to functioning at 5 years of age (Van Baar & De Graaff, 1994) . Almost half the children with a delay at 2 years of age were already showing a delay at 1 year of age. In one study, we found a relationship between impaired infant development at 10-12 months and maternal hypothyroxinaemia during early gestation, but infant development at this early age still has only a limited value regarding the prediction of a child's abilities at later age (Pop et al ., 1999a ). An earlier study (although with small numbers) showed an association between impaired scores at preschool age and elevated titres of TPO-Ab at 32 weeks' gestation but -although this finding was corrected for several psychosocial determinants -this was brought into question because of the relatively long period between pregnancy and assessment during which, for example, emotional or attachment disorders of the infant might interfere with its neurodevelopment (Pop et al ., 1995) . Thus, longitudinal studies are needed in which measurements of maternal function are started during early pregnancy, and infant development is assessed as soon as possible after birth, with regular follow-up of these children until school age at least, taking into account other psychosocial determinants of infant development.
Another limitation is that no careful assessment of daily food intake has been carried out, for example, taking into account the intake of maternal flavonoids (Schroder-van der Elst et al ., 1998) . However, there is no reason to believe that the daily intake of flavonoids during pregnancy would have been significantly different between cases and controls. Although 24-h iodine intake was not assessed either, previous population studies have reported sufficient iodine intake in the general population in this area, while other studies questioned whether this daily intake was sufficient for pregnant women with regard to the fetus (ReesWortelboer et al ., 1987; Brussaard et al ., 1997; Morreale de Escobar & Escobar del Rey, 1999; Utiger, 1999) . Recently, neonates in areas with mild iodine deficiency were shown to be at the limit of thyroid dysfunction as seen by their increased T4, TSH and Tg levels (Eltom et al ., 2001) . The finding of (highly) elevated TSH concentrations during gestation in several studies (Glinoer, 1997; Haddow et al ., 1999) has led to the suggestion of inadequate iodine intake during pregnancy (Brussaard et al ., 1997; Utiger, 1999) . In the present study, the relationship between elevated TSH levels during gestation and infant development was not investigated because women with higher initial TSH were excluded when hypothyroxinaemia was defined.
Finally, it might be questioned whether, in view of the trend in norms for developmental and intelligence tests, the number of children showing developmental delay may even have been underestimated (Fuggle et al ., 1992) . In this regard, it is interesting to note that, in a 1999 study carried out in the same area as the current study, the mean mental and motor scale scores in a group of 198 children from the general population of mothers with an fT4 above the 10th percentile at 12 weeks' gestation, aged 10-12 months, were 108 and 100, respectively (Pop et al ., 1999) , suggesting that the mean scores of the current control group are representative of the general population.
Contrary to what has been hypothesized recently (Pop et al ., 1999) , the results of this study suggest, on the one hand, that screening for fT4 at 12 weeks' gestation could indicate a subgroup of hypothyroxinaemic women whose infants would benefit from an increase of maternal fT4 (e.g. thyroxin treatment) even after the first trimester, which is generally thought of as the most critical stage of gestation due to the lack of fT4 production by the fetus (Burrow et al ., 1994) . On the other hand, it is still unclear whether these women would benefit more from iodine treatment during early pregnancy or from T4 supplementation (Morreale de Escobar et al ., 2000) . It should be realized that, apart from Man & Serunian's (1976) study of several decades ago (before fT4 and sensitive TSH assays were available), no longitudinal follow-up studies have been published of children who were repeatedly assessed during infancy and school age showing a relationship between maternal thyroid functioning during pregnancy and neurodevelopment. Neither are there any studies that show any benefit from maternal thyroxin substitution during early pregnancy and subsequent infant development. In conclusion, maternal hypothyroxinaemia during early gestation has been found to be an independent determinant of a delay in infant neurodevelopment. However, infant development does not seem to be affected in children of mothers who were hypothyroxinaemic during early gestation and in whom subsequently fT4 concentrations increased during pregnancy.
